Carmot Therapeutics Inc. IPO Research Information

Carmot Therapeutics Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Carmot Therapeutics Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Carmot Therapeutics Inc.	CRMO - NASDAQ	Withdrawn	$0.00	$0.00	Withdrawn
Underwriter(s): J.P. Morgan, BofA Securities, Piper Sandler, Guggenheim
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2023-11-17

About Carmot Therapeutics Inc. (adapted from Carmot Therapeutics Inc. prospectus):
They are a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CRMO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.